Nextremity Solutions Receives FDA, CE Mark Approval for Metatarsal Shortening System

Nextremity Solutions announced that it has received clearance from the U.S. Food and Drug Administration and CE Mark certification for its MSP Metatarsal Shortening Plate and System.

Advertisement

The system is positioned for metatarsal shortening osteotomies to correct toe angulation/dislocation and relieve pressure. The company will prepare for a limited product release in the coming weeks.

 

Nextremity Solutions is a privately held medical device company offering solutions and approaches to forefoot surgical intervention.

More Articles on Devices:

5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.